Tag: Goldman

Goldman Team Finds Alternative to Crowded TSMC Arbitrage Trade

(Bloomberg) — It has become one of the most popular — and more recently, painful — trades among arbitrageurs on Wall Street: buying Taiwan Semiconductor Manufacturing Co.’s lower-valued Taipei shares and shorting the US stock on hopes prices will converge. Most Read from Bloomberg Goldman Sachs Group Inc. is now highlighting a zero-cost alternative. Investors […]

Goldman Sachs raises S&P 500 year-end target to 5,600

(Reuters) – Goldman Sachs has raised its 2024 year-end target for the S&P 500 Index to 5,600 from 5,200 earlier, citing strong earnings growth by five mega-cap U.S. tech stocks and a higher fair value price-to-earnings ratio multiple. Microsoft, Nvidia, Google, Amazon.com, and Meta Platforms have collectively surged by 45% and now comprise 25% of […]

Goldman Sachs Boosts S&P 500 Target on Upbeat Profit Outlook

(Bloomberg) — Goldman Sachs Group Inc. strategists have boosted their year-end target for the S&P 500 Index for a third time, reflecting Wall Street’s optimistic outlook for earnings growth and the US economy. Most Read from Bloomberg The bank’s equity strategists led by David Kostin now see the US stock benchmark index finishing the year […]

‘Load Up,’ Says Goldman Sachs About These 2 Strong Buy Stocks

Stock picking is going to get a bit more difficult in the near term, if the word coming out of Goldman Sachs is accurate. The firm’s strategist, Peter Oppenheimer, sees a combination of rising bond yields and high stock valuations working together to tighten up overall gains in the equity markets. “The faster any rise […]

Goldman Sachs Says Buy European Pharma Stocks Touting Innovation

(Bloomberg) — European drugmakers that are focused on building portfolios of new medicines have gotten a nod from analysts at Goldman Sachs Group Inc. Most Read from Bloomberg The analysts initiated coverage of six large-cap pharmaceutical stocks on Thursday, saying “innovation is the key to success.” They gave buy ratings to AstraZeneca Plc, Novo Nordisk […]

Cleveland Fed Names Goldman Veteran Beth Hammack as President

(Bloomberg) — The Federal Reserve Bank of Cleveland appointed Beth Hammack, a Goldman Sachs Group Inc. veteran, as its next president. Most Read from Bloomberg Hammack, who was most recently co-head of global financing at the Wall Street heavyweight, has more than three decades of experience in finance, capital markets, and risk management. She will […]

Goldman Sachs Predicts up to 108% Rally for These 2 ‘Strong Buy’ Stocks

Given the S&P 500‘s recent surge beyond 5,300, surpassing some experts’ year-end targets, is it prudent for investors to be concerned about a potential overheating in the market? Goldman Sachs’ chief US equity strategist David Kostin believes that now that the S&P has climbed above the 5,200 target he’d predicted, there just isn’t much more […]